Delayed impairment of cerebral oxygenation after deep hypothermic circulatory arrest in children.

Ann Thorac Surg

Hospital for Children and Adolescents, and Department of Obstetrics and Gynecology, University of Helsinki, Finland.

Published: June 1999

Background: Clinical studies of deep hypothermic circulatory arrest (DHCA) have focused only on the immediate postoperative period. However, experimental findings suggest impairment of cerebral oxygenation at 2 to 8 hours after reperfusion.

Methods: In 10 children who had DHCA for heart operations, transcerebral differences of hemoglobin oxygen saturation and plasma hypoxanthine, xanthine, and lactoferrin concentrations were measured in concurrently obtained cerebral venous, arterial, and mixed venous samples up to 10 hours postoperatively.

Results: Compared with preoperative levels (57% +/- 7%), cerebral venous oxygen saturation was not significantly reduced until 2 hours (44% +/- 6%) and 6 hours (42% +/- 5%) after DHCA (p < 0.05). A statistically significant transcerebral (ie, cerebral vein versus artery) concentration difference of hypoxanthine was observed at 30 minutes (3.6 +/- 0.9 micromol/L), 1 hour (3.4 +/- 1.1 micromol/L), and 2 hours (3.1 +/- 0.8 micromol/L) after DHCA but not preoperatively (0.4 +/- 0.2 micromol/L). A transcerebral concentration difference of lactoferrin occurred 30 minutes after DHCA (196 +/- 70 microg/mL) but not preoperatively (16 +/- 20 microg/mL).

Conclusions: Cerebral venous oxygen saturation of hemoglobin decreased as late as 2 to 6 hours after DHCA, in association with impaired cerebral energy status. Neutrophil activation in the cerebral circulation occurred 30 minutes after reperfusion.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-4975(99)00320-3DOI Listing

Publication Analysis

Top Keywords

+/- micromol/l
16
oxygen saturation
12
cerebral venous
12
+/-
9
cerebral
8
impairment cerebral
8
cerebral oxygenation
8
deep hypothermic
8
hypothermic circulatory
8
circulatory arrest
8

Similar Publications

 Neuronal ceroid lipofuscinosis-type 1 (NCL-1) is a neurodegenerative lysosomal storage disorder. Vitamin D-dependent rickets type 1 (VDDR-1) is a rare cause of refractory rickets. Here, we report an unusual association of NCL-1 with VDDR-1.

View Article and Find Full Text PDF

Purpose: We described our experience in the management of PUV at UNIOSUN Teaching Hospital, Osogbo, Osun State.

Methods: This was a retrospective analysis of patients with diagnosis of PUV carried out over a 4 year period (2019-2023). Demographic characteristics, clinical presentation, diagnosis and mode of therapeutic interventions were the variables analysed.

View Article and Find Full Text PDF

Background: Pre-eclampsia is a syndrome that chiefly includes the development of new-onset hypertension and proteinuria after 20 weeks of pregnancy. Pre-eclampsia is one of the major causes of mortality and morbidity in Nepal. Hyperhomocysteinemia may be a cause of the endothelial dysfunction provoked by oxidative stress in pre-eclampsia.

View Article and Find Full Text PDF

First successful outcomes of pegvaliase (PALYNZIQ) in children.

BMC Med Genomics

March 2024

College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNG-HA), Riyadh, Saudi Arabia.

Article Synopsis
  • - PKU is a genetic disorder caused by a deficiency in the enzyme phenylalanine hydroxylase, leading to high levels of phenylalanine in the blood; pegvaliase (PALYNZIQ®) has been approved for treating adults with uncontrolled Phe levels above 600 micromol/L, but its effects on children under 16 are not well-studied.
  • - A case study of a 12-year-old Saudi girl who received pegvaliase therapy showed significant improvement in her blood Phe levels after six months, allowing her to maintain a normal diet without restrictions while keeping her Phe levels stable.
  • - The findings suggest pegvaliase may be safe and effective for children with PKU, highlighting
View Article and Find Full Text PDF

Background Placenta-mediated complications, such as preeclampsia, placental abruption, and fetal growth restriction, can indeed lead to significant maternal and perinatal morbidity and mortality. Early detection and management of these conditions are crucial to ensuring optimal outcomes for both the mother and baby. However, there have been inconsistent correlations found between maternal homocysteine levels and placenta-related problems in various studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!